Published Mar 13, 2023
Prof G Markets: Scott’s NJOY Stake, the JetBlue/Spirit Merger, and WeightWatchers Buys Ozempic Maker
Scott Galloway explores the intricacies of investment diversification through his NJOY experience, scrutinizes the JetBlue-Spirit merger amid antitrust challenges, and evaluates WeightWatchers' strategic shift into obesity treatment with its acquisition of an Ozempic maker, providing a comprehensive look at pivotal trends in finance, aviation, and health.

Topics covered
Popular Clips
Episode Highlights
Related Episodes


Prof G Markets: Is Boeing a Buy? AI Picks & Shovels (and Scott’s Ketamine Trip)
Answers 383 questions
Prof G Markets: Scott’s Nine Businesses
Answers 383 questions
Prof G Markets: Scott’s Investment Portfolio — a Breakdown
Answers 383 questions

Prof G Markets: Rivian and Volkswagen’s New Partnership + Scott’s Tax Strategy
Answers 383 questions
Prof G Markets: Netflix’s New Entertainment Venues & Scott’s Takeaways from Cannes
Answers 383 questions
Prof G Markets: How Scott Manages His Money
Answers 383 questions
Scott’s Investment Portfolio — a Breakdown | Prof G Markets
Answers 383 questions
